Condition 1: head trauma patients. Condition 2: thorax trouma. ????? ?? ?? ?????? ???? ????
Conditions
Interventions
Intervention group:Two groups of 20 people receiving dexmedetomidine and propofol.
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: The entry criteria for the study, including all people with trauma in the ICU, and the age range of 18-55 years and the presence of a companion, will be considered as the entry criteria. They are distributed randomly
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic changes and delirium. Timepoint: 16-12-24-48 hours after starting the drug. Method of measurement: questionnaire. | — |
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic changes and delirium. Timepoint: 3 months. Method of measurement: This study is a clinical trial study that will be conducted on 40 trauma patients with an age range of 18-55 years, divided into two groups, that is, under anesthesia with propofol and under anesthesia with dexmedetomidine. In the end, 20 people from each group will be tested for a total of 40 people. Considering the first type error of 5% and the power of 80% and the ability to show the average difference between the two groups that is statistically significant (size effect = 0.5), 20 cases were considered for each group. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Hamid Pakzad
Rafsanjan University of Medical Sciences
Outcome results
None listed